Skip to main content

What the FDA labels say about taking them together

Glucagon and paltusotine

Paltusotine's FDA label of September 16, 2025 names glucagon in its warnings and precautions section; the glucagon labels PlainMeds reads (4) do not name paltusotine. The paltusotine label: “Hyperglycemia and Hypoglycemia PALSONIFY may alter the balance between the counter-regulatory hormones, insulin, glucagon, and growth hormone, which may result in hypoglycemia, hyperglycemia, or diabetes mellitus.”

Check it at the source: the glucagon FDA label on DailyMed (effective August 11, 2026, Amphastar Pharmaceuticals, Inc.); the paltusotine FDA label on DailyMed (effective September 16, 2025, Crinetics Pharmaceuticals, Inc.).

What does the glucagon label say about paltusotine?

Glucagon's label (effective August 11, 2026) and its 3 other brand-application labels do not name paltusotine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Glucagon), Amphastar Pharmaceuticals, Inc., effective August 11, 2026 (SPL set 8cc40354-b5ac-45b6-a211-93b44444f2a3), via openFDA; the full label on DailyMed

What does the paltusotine label say about glucagon?

Paltusotine label, warnings and precautions

Hyperglycemia and Hypoglycemia PALSONIFY may alter the balance between the counter-regulatory hormones, insulin, glucagon, and growth hormone, which may result in hypoglycemia, hyperglycemia, or diabetes mellitus.

Source: FDA drug label (PALSONIFY), Crinetics Pharmaceuticals, Inc., effective September 16, 2025 (SPL set 8a6d2ce0-a621-4ee7-983c-977cd948ff4d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

6Glucagon generic labelers
0Paltusotine generic labelers
GlucagonPaltusotine
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)$154.20 per kit 1 mg emergency kitn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?